Historical Healthcare Moment · July 2026
Protecting Access to
Homeopathic Medicine
Legislation is moving forward that will shape the future of homeopathy in the United States – and your voice matters.
|
200+ Years in Use |
50+ Supporting Organizations |
45,000 Signatures & Counting |
2 Bills in Congress Now |
We stand at a unique and important moment in the history of homeopathy in the United States. Legislation is being advanced in the US House of Representatives (H.R. 7050) and US Senate (S.4692) that will protect access to homeopathic medicine for our future.
Both bills are moving forward with the support of more than 50 national and state organizations, manufacturers, and healthcare advocates. This process can help to secure a legal pathway and protect access to the full range of formulations for generations to come.
We at Deseret Biologicals rely heavily in many of our formulations on homeopathic medicines. We are striving to create an understanding that for over 200 years homeopathic medicines have been used safely and effectively. We are currently working to get Congress to pass a law that protects and stabilizes the status of homeopathic medicines in the United States.
Your support is needed.
The Issue
Why Is This Needed?
The U.S. Food and Drug Administration (FDA) finalized new guidelines for homeopathic drugs that give the agency the power to remove properly formulated homeopathic products previously legal under the Federal Food, Drug & Cosmetic Act which governs the FDA.
In addition, since the FDA has withdrawn its previous policy – which outlined clear steps for bringing homeopathic medicines to market – the agency provided no clear guidance on how manufacturers should comply with the law. The results so far have been chaos and the removal of two entire categories of homeopathic medicines: Injectables and Ophthalmics. There is concern that other categories of homeopathic medicines may be affected in the future.
The agency’s abrupt moves have thrown manufacturers, practitioners, consumers and, indeed, the entire homeopathy community into confusion and uncertainty.
It is of great concern that the FDA is singling out homeopathic medicines. The FDA does not, as a matter of policy, threaten to remove much more widely used OTC medications.
What Changed
Homeopathic Medicines Are Now Officially “Unapproved”
The final guidelines change the status of homeopathic drugs from a special category of medicine and put them into a group considered “unapproved.” This means that all homeopathic medicines are technically illegal and may be removed at any time by order of the FDA.
Any homeopathic drug removed from the market by the FDA could not return unless it undergoes the agency’s New Drug Application (NDA) process – a costly process designed to weigh the risks and benefits of pharmaceutical drugs which may have toxic effects.
Homeopathic medicines are formulated to be nontoxic and therefore pose minimal toxic threat to humans. Since homeopathic medicines cannot be patented – they consist of commonly available substances – there is no incentive for any company to pay for such a process.
What’s at Stake
Categories at Risk
The FDA’s enforcement priorities in its new guidelines include “[i]ngredients that pose a risk of toxic, or other adverse effects.” This is an explicit targeting of common homeopathic ingredients. These are all potentially toxic in their raw starting material form, but are diluted far beyond any toxic level before use – and yet, they may become unavailable depending on how the FDA’s enforcement division interprets this language:
Sarcodes
Aconitum napellus
Arsenicum album
Gelsemium sempervirens
Lachesis mutus
Mercurius solubilus
Nux vomica
Pulsatilla nigra
Rhus toxicodendron
The FDA has already taken two entire categories of homeopathic drugs off the market – injectables administered exclusively by physicians for pain control and homeopathic eye drops. These losses happened quickly and according to the FDA, all homeopathic medicines are vulnerable to actions such as these.
The case of Philadelphia-based homeopathic manufacturer and importer MediNatura was the first of what could be a series of actions by the FDA to remove homeopathic medicines from the market. MediNatura was forced by financial considerations to drop its case against the FDA after a U.S. appeals court refused to grant a preliminary injunction to prevent the agency from blocking imports of MediNatura’s injectable homeopathic drugs.
From the Court Record
“The FDA admitted in a lower court hearing that the agency has no evidence of safety problems with MediNatura’s products.”
Rather, the FDA asserted that the injectable drugs are “unapproved new drugs” which have not gone through a New Drug Application process and which are subject to removal at any time merely because they are “unapproved.” The FDA claimed to be targeting homeopathic drugs it regards as “risky.” MediNatura asserts that its products are neither risky nor “new drugs” under the law.
In late 2023, the FDA updated an import alert to include homeopathic eye drops supplied by six companies. At that time all homeopathic eye drops sold in the United States were manufactured abroad. The alert directs U.S. Immigration and Customs Enforcement to block importation of homeopathic eye drops because they are “unapproved new drugs” which cannot be marketed legally in the United States. The FDA also stated that health claims made on the eye drops’ product labels regarding specific conditions such as pink eye were not substantiated.
|
The Organization Leading This Fight |
 |
AFHC has been working diligently for the last seven years to address this situation. The mission of the AFHC is “to restore and protect access to the full range of homeopathic medicines for all Americans while ensuring the safety of those medicines.”
At this point, their mission requires the seeking of bipartisan federal legislation. They believe that any legislation that seeks to ensure access to the full range of homeopathic medicines should also seek to create conditions that will maintain a diversity of suppliers in a resilient and competitive marketplace. This will serve consumers and practitioners by making sure the full range is available and affordable while also setting the stage for innovation in homeopathic medicine.
This legislation is supported by an unprecedented coalition of 50+ leading national and state homeopathy organizations, holistic health nonprofits, manufacturers, retailers, and advocacy groups who have formally signed a Statement of Support. DesBio has signed this statement. Their collective endorsement sends a strong message to Congress that the homeopathy and natural health community is united, informed, and ready for a lasting legislative solution.
📝 Signatures Toward the Goal
45,000 of 90,000
Every signature counts. Add yours today →
Take Action
How Can You Help?
There are four ways in which you can support this important effort. Your voice is critical.
| 01 |
Sign the Statement of Support You can sign a statement of support for these initiatives. DesBio has signed this statement. At the time of this writing, there have been 45,000 comments with a goal of 90,000. |
| 02 |
Sign Up for Free Membership & Updates You can sign up for free membership with Americans for Homeopathic Choice. Your free membership keeps you informed through regular updates and their monthly newsletter Homeopathy Choice Insider. You’ll also receive Action Alerts with pre-written messages automatically directed to your elected representatives in Congress. Because those members are hearing from you as a constituent and a voter, they pay attention. |
| 03 |
Donate Donations from yourself or your patients are welcome to fund this effort. Financial support directly enables the legislative advocacy that protects homeopathic access for everyone. Every dollar helps. |
| 04 |
Join a Political Action Team The AFHC priority is to grow their Homeopathy Action Team (HAT). HAT members focus on building relationships with their elected representatives in Congress – crucial as we move forward with legislation to secure the future of homeopathy in America. AFHC provides training, scripts, and talking points along with opportunities to work alongside your team members and your state captain. The time commitment once you get rolling is just a few hours a month. Onboarding for training occurs once a year, so you may need to put your name on a waiting list so that we’ll know to contact you when the time comes. |
The Bottom Line
For over 200 years, homeopathic medicines have supported the health of millions safely and effectively. The legislative pathway being pursued through H.R. 7050 and S.4692 represents the clearest route to securing the future of these medicines in the United States. DesBio stands with this effort. We encourage every practitioner and patient in our community to add their voice.
DesBio empowers practitioners and their patients through targeted supplements and homeopathic remedies. We are more than just a product company – we are a partner in your practice and a voice in the broader natural health community.
Join Our Practitioner Community
If you are a healthcare practitioner and would like to join our DesBio practitioner community, take the next step today.